Affiliation:
1. Health Radiation Research Department, National Center for Radiation Research and Technology Egyptian Atomic Energy Authority Cairo Egypt
2. Department of Drug Radiation Research, National Center for Radiation Research & Technology Egyptian Atomic Energy Authority Cairo Egypt
3. Internal Medicine Unit, Health Radiation Research Department, National Center for Radiation Research and Technology Egyptian Atomic Energy Authority Cairo Egypt
Abstract
AbstractThroughout radiotherapy, radiation of the hepatic tissue leads to damage of the hepatocytes. We designed the current study to examine how cerium oxide nanoparticles (CONPs) modulate gamma irradiation‐induced hepatotoxicity in rats. Animals received CONPs (15 mg/kg body weight [BW], ip) single daily dose for 14 days, and they were exposed on the seventh day to a single dose of gamma radiation (6 Gy). Results showed that irradiation increased serum aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase activities. Furthermore, it elevated oxidative stress biomarker; malondialdehyde (MDA) and inhibited the activities of antioxidant enzymes (superoxide dismutase and glutathione peroxidase) in hepatic tissues homogenate. Additionally, hepatic apoptotic markers; caspase‐3 (Casp‐3) and Casp‐9 were elevated and the B‐cell lymphoma‐2 (Bcl‐2) gene level was decreased in rats exposed to radiation dose. We observed that CONPs can modulate these changes, where CONPs reduced liver enzyme activities, MDA, and apoptotic markers levels, in addition, it elevated antioxidant enzyme activities and Bcl‐2 gene levels, as well as improved histopathological changes in the irradiated animals. So our results concluded that CONPs had the ability to act as radioprotector defense against hepatotoxicity resulted during radiotherapy.